NASDAQ · Agricultural Inputs · USD
Nexentis Technologies Inc. (NXTS) Stock Analysis
Nexentis Technologies Inc. (NXTS) is a Agricultural Inputs stock listed on NASDAQ and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
NXTS Key Statistics
As of Oct 21, 2026Trading
- Open
- $0.61
- Previous Close
- $0.62
- Day's Range
- 0.50–0.61
- 52-Week Range
- 0.50–30.28
- Volume
- 148.87K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 1.86
Valuation
- Market Cap
- $787.27K
- P/E Ratio
- unprofitable
- EPS (ttm)Profit attributable to each share over the last twelve months.
- −21.55
Financials (FY)
- Revenue (FY)
- $0.00
- Net Income (FY)
- −$4.00M
- Shares Outstanding
- 1.45M
- 1-Year Return
- −98.07%
Dividend and dates
- Avg Volume
- 354.90K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, NXTS closed at $0.54, −98.07% over 1 year.
Nexentis Technologies Inc. (NXTS) has a market capitalization of $787.27K.
In fiscal 2025, NXTS reported revenue of $0.00.
NXTS Stock Return by Calendar Year
Nexentis Technologies Inc. (NXTS) 10-year return: what $10,000 became
- 1 year
- $10,000 $193
- −98.07%
- 5 years
- $10,000 $0.50
- −99.995%
- 10 years
- $10,000 $0.17
- −99.998%
If you had invested $10,000 in Nexentis Technologies Inc. (NXTS) 10 years ago, at the close on October 21, 2016, it would have been worth $0.17 at the close on October 21, 2026: −99.998% in total, −66.71% a year. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | −95.39% |
| 2025 | −80.65% |
| 2024 | −87.60% |
| 2023 | −62.16% |
| 2022 | −81.17% |
| 2021 | −53.43% |
| 2020 | +2.50% |
| 2019 | +60.00% |
| 2018 | −50.00% |
| 2017 | +0.00% |
| 2016 (partial year) | −64.29% |
As of October 21, 2026.
NXTS Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $0.00 | −$4.00M | — |
| 2024 | $0.00 | −$5.19M | — |
| 2023 | $263.00K | −$6.52M | −2,479.8% |
| 2022 | $394.00K | −$5.74M | −1,456.7% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $0.00 | — | −$5.37M | −$4.00M | — |
| 2024 | $0.00 | $45.00K | −$3.28M | −$5.19M | — |
| 2023 | $263.00K | $208.00K | −$7.54M | −$6.52M | −2,479.8% |
| 2022 | $394.00K | $235.69K | −$5.82M | −$5.74M | −1,456.7% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
Recent News
Nexentis: MitoCareX Bio Expands Computational Biology Capabilities to Advance Disease-Pathway Analysis
YahooNexentis Deploys MitoCareX Computational Drug Discovery Infrastructure on Google Cloud
InvestorsHubNexentis: MitoCareX Bio Deploys its Computational Drug Discovery Infrastructure on Google Cloud
YahooNexentis Technologies Unit MitoCareX Bio Launches Its Computational Drug Discovery Infrastructure On Google Cloud Platform
BenzingaNexentis: MitoCareX Strengthens Its Computational Drug Discovery Capabilities with Appointment of Prof. Dan T. Major to Scientific Advisory Board
YahooNexentis: MitoCareX Evaluates Expanded Protein Capabilities to Enhance Flexibility and Support Future Drug Discovery
Yahoo
All 7 articles ↓Show fewer ↑
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Agricultural Inputs Stocks
Nutrien Ltd.
$32.51B
CFCF Industries Holdings, Inc.
$18.29B
CTVACorteva, Inc.
$8.49B
MOSThe Mosaic Company
$5.62B
SMGThe Scotts Miracle-Gro Company
$3.26B
FMCFMC Corporation
$782.40M
Popular Basic Materials Stocks
Linde plc
$230.75B
BHPBHP Group Limited
$211.50B
SCCOSouthern Copper Corporation
$167.24B
RIORio Tinto Group
$141.37B
NEMNewmont Corporation
$123.47B





